Exponent, Inc. (NASDAQ:EXPO - Get Free Report) announced a quarterly dividend on Thursday, October 24th, Zacks reports. Shareholders of record on Friday, December 6th will be paid a dividend of 0.28 per share by the business services provider on Friday, December 20th. This represents a $1.12 dividend on an annualized basis and a yield of 1.16%. The ex-dividend date is Friday, December 6th.
Exponent has raised its dividend payment by an average of 11.0% annually over the last three years and has increased its dividend annually for the last 11 consecutive years. Exponent has a dividend payout ratio of 53.3% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect Exponent to earn $2.10 per share next year, which means the company should continue to be able to cover its $1.12 annual dividend with an expected future payout ratio of 53.3%.
Exponent Stock Down 8.9 %
NASDAQ:EXPO traded down $9.44 during trading hours on Friday, reaching $96.92. 370,086 shares of the stock were exchanged, compared to its average volume of 180,836. The firm has a 50 day simple moving average of $108.99 and a 200-day simple moving average of $100.16. Exponent has a 52 week low of $64.61 and a 52 week high of $115.75. The stock has a market capitalization of $4.92 billion, a P/E ratio of 47.28 and a beta of 0.66.
Exponent (NASDAQ:EXPO - Get Free Report) last released its earnings results on Thursday, October 24th. The business services provider reported $0.50 EPS for the quarter, topping analysts' consensus estimates of $0.48 by $0.02. Exponent had a return on equity of 28.39% and a net margin of 19.35%. The company had revenue of $125.09 million for the quarter, compared to the consensus estimate of $125.96 million. As a group, analysts expect that Exponent will post 2.04 earnings per share for the current year.
Insider Buying and Selling
In other Exponent news, VP John Pye sold 3,956 shares of Exponent stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $105.00, for a total transaction of $415,380.00. Following the sale, the vice president now owns 28,422 shares of the company's stock, valued at $2,984,310. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 2.10% of the company's stock.
Wall Street Analyst Weigh In
Separately, Truist Financial reissued a "buy" rating and issued a $120.00 price target (up previously from $100.00) on shares of Exponent in a report on Friday, July 26th.
Read Our Latest Stock Analysis on EXPO
About Exponent
(
Get Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Articles
Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.